Coverage
Filings
| Filing | Date |
|---|---|
| Reporting of transactions involving shares in Ambu A/S | 15 Nov 2013 |
| Announcement of financial statements 2012/13 | 14 Nov 2013 |
| Launch of Global Incentive Programme | 14 Nov 2013 |
| FDA market clearance of Ambu aScope 3 | 6 Nov 2013 |
| King Systems Receives FDA Warning Letter | 29 Oct 2013 |
| Financial Diary 2013/14 | 24 Sept 2013 |
| Major Shareholder Announcement | 11 Sept 2013 |
| Major Shareholder Announcement | 9 Sept 2013 |
Danish medical device maker Ambu on Wednesday reported double-digit revenue growth for its 2024/25 fiscal year and launched a new strategy aimed at achieving global leadership in the single-use endoscopy market.
Danish medical device maker Ambu A/S on Wednesday launched a new strategy aimed at achieving global leadership in the single-use endoscopy market as it reported full-year results in line with its guidance.
Danish medical device maker Ambu A/S on Tuesday raised its long-term growth targets as part of a new strategic plan, building on what it called a successful financial turnaround.
Medical device maker Ambu A/S on Friday cut its full-year free cash flow forecast, citing negative impacts from foreign exchange rates and tariff costs, even as it reported solid quarterly growth.
| Reporting of transactions involving shares in Ambu A/S |
| 4 Sept 2013 |
| Reporting of transactions involving shares in Ambu A/S | 21 Aug 2013 |
| Reporting of transactions involving shares in Ambu A/S | 21 Aug 2013 |
| Interim report for Q3 2012/13 (1 April - 30 June) | 20 Aug 2013 |